Ark Biosciences

OverviewSuggest Edit

Ark Biosciences (爱科百发生物医药是) is a company that specializes in antiviral and respiratory drug development. It aims to provide treatments for a chronic obstructive pulmonary disease (COPD), respiratory syncytial virus (RSV), idiopathic pulmonary fibrosis (IPF) as well as hepatitis B virus (HBV).

TypePrivate
Founded2014
HQCN
Websitearkbiosciences.com

Locations

Ark Biosciences is headquartered in
China

Location Map

Latest Updates

Employees (est.) (Jun 2020)3(-25%)
Cybersecurity ratingBMore

Ark Biosciences Office Locations

Ark Biosciences has an office in
Show all (1)

Ark Biosciences Financials and Metrics

Summary Metrics

Founding Date

2014

Ark Biosciences total Funding

$40 m

Ark Biosciences latest funding size

$32 m

Time since last funding

2 years ago

Ark Biosciences investors

Ark Biosciences's latest funding round in June 2018 was reported to be $32 m. In total, Ark Biosciences has raised $40 m
Show all financial metrics

Ark Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Ark Biosciences Online and Social Media Presence

Embed Graph

Ark Biosciences Frequently Asked Questions

  • When was Ark Biosciences founded?

    Ark Biosciences was founded in 2014.

  • How many employees does Ark Biosciences have?

    Ark Biosciences has 3 employees.

  • Who are Ark Biosciences competitors?

    Competitors of Ark Biosciences include Biogen, Athersys and Radius Health.

  • Where are Ark Biosciences offices?

    Ark Biosciences has an office in.

  • How many offices does Ark Biosciences have?

    Ark Biosciences has 1 office.